Functional expression of CD134 by neutrophils

被引:64
作者
Baumann, R
Yousefi, S
Simon, D
Russmann, S
Mueller, C
Simon, HU
机构
[1] Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland
[2] Univ Bern, Dept Dermatol, Bern, Switzerland
[3] Univ Bern, Dept Clin Pharmacol, Bern, Switzerland
[4] Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland
关键词
apoptosis; caspase; inflammation; neutrophils; OX40;
D O I
10.1002/eji.200424863
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD134 (OX40) is a member of the tumor necrosis factor (TNF) receptor superfamily expressed on activated T cells. Here, we show that human peripheral blood neutrophils express CD134. Activation of CD134 by soluble CD134 ligand (OX40 ligand/gp34) resulted in delayed caspase-3 activation and consequently in delayed neutrophil apoptosis in vitro. Moreover, CD134 ligand,like G-CSF, maintained anti-apoptotic Mcl-1 levels and inhibited cleavage of the pro-apoptotic Bcl-2 family members Bid and Bax in these cells, suggesting that CD134-mediated signals block apoptosis pathways proximal to mitochondria activation. In conclusion, CD134 regulates neutrophil survival, suggesting that this molecule does not only contribute to adaptive but also to innate immune responses.
引用
收藏
页码:2268 / 2275
页数:8
相关论文
共 40 条
[31]   ANTIGENS OF ACTIVATED RAT T LYMPHOCYTES INCLUDING A MOLECULE OF 50,000 MR DETECTED ONLY ON CD4 POSITIVE T-BLASTS [J].
PATERSON, DJ ;
JEFFERIES, WA ;
GREEN, JR ;
BRANDON, MR ;
CORTHESY, P ;
PUKLAVEC, M ;
WILLIAMS, AF .
MOLECULAR IMMUNOLOGY, 1987, 24 (12) :1281-1290
[32]   OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells [J].
Rogers, PR ;
Song, JX ;
Gramaglia, I ;
Killeen, N ;
Croft, M .
IMMUNITY, 2001, 15 (03) :445-455
[33]   Neutrophil apoptosis pathways and their modifications in inflammation [J].
Simon, HU .
IMMUNOLOGICAL REVIEWS, 2003, 193 (01) :101-110
[34]  
Stüber E, 2000, EUR J CLIN INVEST, V30, P594
[35]   Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers [J].
Vetto, JT ;
Lum, S ;
Morris, A ;
Sicotte, M ;
Davis, J ;
Lemon, M ;
Weinberg, A .
AMERICAN JOURNAL OF SURGERY, 1997, 174 (03) :258-265
[36]   Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis [J].
Weinberg, AD ;
Bourdette, DN ;
Sullivan, TJ ;
Lemon, M ;
Wallin, JJ ;
Maziarz, R ;
Davey, M ;
Palida, F ;
Godfrey, W ;
Engleman, E ;
Fulton, RJ ;
Offner, H ;
Vandenbark, AA .
NATURE MEDICINE, 1996, 2 (02) :183-189
[37]   Engagement of the OX-40 receptor in vivo enhances antitumor immunity [J].
Weinberg, AD ;
Rivera, MM ;
Prell, R ;
Morris, A ;
Ramstad, T ;
Vetto, JT ;
Urba, WJ ;
Alvord, G ;
Bunce, C ;
Shields, J .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :2160-2169
[38]   OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines [J].
Weinberg, AD .
TRENDS IN IMMUNOLOGY, 2002, 23 (02) :102-109
[39]  
Yoshioka T, 2000, EUR J IMMUNOL, V30, P2815, DOI 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO
[40]  
2-#